Medical Care
Global Pet Anthelmintic Drugs Market Research Report 2025
- Jul 08, 25
- ID: 348368
- Pages: 85
- Figures: 86
- Views: 34
The global market for Pet Anthelmintic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 45%.
This report aims to provide a comprehensive presentation of the global market for Pet Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Anthelmintic Drugs.
The Pet Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
Virbac
Zoetis
Segment by Type
External
Internal
Composite
Injection
Segment by Application
Dog
Cat
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Anthelmintic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 45%.
This report aims to provide a comprehensive presentation of the global market for Pet Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Anthelmintic Drugs.
The Pet Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
Virbac
Zoetis
Segment by Type
External
Internal
Composite
Injection
Segment by Application
Dog
Cat
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Anthelmintic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 External
1.2.3 Internal
1.2.4 Composite
1.2.5 Injection
1.3 Market by Application
1.3.1 Global Pet Anthelmintic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Anthelmintic Drugs Market Perspective (2020-2031)
2.2 Global Pet Anthelmintic Drugs Growth Trends by Region
2.2.1 Global Pet Anthelmintic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pet Anthelmintic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Pet Anthelmintic Drugs Market Dynamics
2.3.1 Pet Anthelmintic Drugs Industry Trends
2.3.2 Pet Anthelmintic Drugs Market Drivers
2.3.3 Pet Anthelmintic Drugs Market Challenges
2.3.4 Pet Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2020-2025)
3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pet Anthelmintic Drugs Revenue
3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2024
3.5 Global Key Players of Pet Anthelmintic Drugs Head office and Area Served
3.6 Global Key Players of Pet Anthelmintic Drugs, Product and Application
3.7 Global Key Players of Pet Anthelmintic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Anthelmintic Drugs Breakdown Data by Type
4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2026-2031)
5 Pet Anthelmintic Drugs Breakdown Data by Application
5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pet Anthelmintic Drugs Market Size (2020-2031)
6.2 North America Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pet Anthelmintic Drugs Market Size by Country (2020-2025)
6.4 North America Pet Anthelmintic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Anthelmintic Drugs Market Size (2020-2031)
7.2 Europe Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pet Anthelmintic Drugs Market Size by Country (2020-2025)
7.4 Europe Pet Anthelmintic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Pet Anthelmintic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Anthelmintic Drugs Market Size (2020-2031)
9.2 Latin America Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pet Anthelmintic Drugs Market Size by Country (2020-2025)
9.4 Latin America Pet Anthelmintic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Pet Anthelmintic Drugs Introduction
11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.1.5 Elanco Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.3.5 Ceva Sante Animale Recent Development
11.4 Chanelle Group
11.4.1 Chanelle Group Company Details
11.4.2 Chanelle Group Business Overview
11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.4.5 Chanelle Group Recent Development
11.5 Dechra
11.5.1 Dechra Company Details
11.5.2 Dechra Business Overview
11.5.3 Dechra Pet Anthelmintic Drugs Introduction
11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.5.5 Dechra Recent Development
11.6 Durvet
11.6.1 Durvet Company Details
11.6.2 Durvet Business Overview
11.6.3 Durvet Pet Anthelmintic Drugs Introduction
11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.6.5 Durvet Recent Development
11.7 First Priority
11.7.1 First Priority Company Details
11.7.2 First Priority Business Overview
11.7.3 First Priority Pet Anthelmintic Drugs Introduction
11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.7.5 First Priority Recent Development
11.8 Jeffers
11.8.1 Jeffers Company Details
11.8.2 Jeffers Business Overview
11.8.3 Jeffers Pet Anthelmintic Drugs Introduction
11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.8.5 Jeffers Recent Development
11.9 Manna Pro Products
11.9.1 Manna Pro Products Company Details
11.9.2 Manna Pro Products Business Overview
11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.9.5 Manna Pro Products Recent Development
11.10 Merck Animal Health
11.10.1 Merck Animal Health Company Details
11.10.2 Merck Animal Health Business Overview
11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.10.5 Merck Animal Health Recent Development
11.11 Ourofino
11.11.1 Ourofino Company Details
11.11.2 Ourofino Business Overview
11.11.3 Ourofino Pet Anthelmintic Drugs Introduction
11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.11.5 Ourofino Recent Development
11.12 TTK Healthcare
11.12.1 TTK Healthcare Company Details
11.12.2 TTK Healthcare Business Overview
11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.12.5 TTK Healthcare Recent Development
11.13 Vetoquinol
11.13.1 Vetoquinol Company Details
11.13.2 Vetoquinol Business Overview
11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.13.5 Vetoquinol Recent Development
11.14 Virbac
11.14.1 Virbac Company Details
11.14.2 Virbac Business Overview
11.14.3 Virbac Pet Anthelmintic Drugs Introduction
11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.14.5 Virbac Recent Development
11.15 Zoetis
11.15.1 Zoetis Company Details
11.15.2 Zoetis Business Overview
11.15.3 Zoetis Pet Anthelmintic Drugs Introduction
11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.15.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 External
1.2.3 Internal
1.2.4 Composite
1.2.5 Injection
1.3 Market by Application
1.3.1 Global Pet Anthelmintic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Anthelmintic Drugs Market Perspective (2020-2031)
2.2 Global Pet Anthelmintic Drugs Growth Trends by Region
2.2.1 Global Pet Anthelmintic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pet Anthelmintic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Pet Anthelmintic Drugs Market Dynamics
2.3.1 Pet Anthelmintic Drugs Industry Trends
2.3.2 Pet Anthelmintic Drugs Market Drivers
2.3.3 Pet Anthelmintic Drugs Market Challenges
2.3.4 Pet Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2020-2025)
3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pet Anthelmintic Drugs Revenue
3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2024
3.5 Global Key Players of Pet Anthelmintic Drugs Head office and Area Served
3.6 Global Key Players of Pet Anthelmintic Drugs, Product and Application
3.7 Global Key Players of Pet Anthelmintic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Anthelmintic Drugs Breakdown Data by Type
4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2026-2031)
5 Pet Anthelmintic Drugs Breakdown Data by Application
5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pet Anthelmintic Drugs Market Size (2020-2031)
6.2 North America Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pet Anthelmintic Drugs Market Size by Country (2020-2025)
6.4 North America Pet Anthelmintic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Anthelmintic Drugs Market Size (2020-2031)
7.2 Europe Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pet Anthelmintic Drugs Market Size by Country (2020-2025)
7.4 Europe Pet Anthelmintic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Pet Anthelmintic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Anthelmintic Drugs Market Size (2020-2031)
9.2 Latin America Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pet Anthelmintic Drugs Market Size by Country (2020-2025)
9.4 Latin America Pet Anthelmintic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Pet Anthelmintic Drugs Introduction
11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.1.5 Elanco Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.3.5 Ceva Sante Animale Recent Development
11.4 Chanelle Group
11.4.1 Chanelle Group Company Details
11.4.2 Chanelle Group Business Overview
11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.4.5 Chanelle Group Recent Development
11.5 Dechra
11.5.1 Dechra Company Details
11.5.2 Dechra Business Overview
11.5.3 Dechra Pet Anthelmintic Drugs Introduction
11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.5.5 Dechra Recent Development
11.6 Durvet
11.6.1 Durvet Company Details
11.6.2 Durvet Business Overview
11.6.3 Durvet Pet Anthelmintic Drugs Introduction
11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.6.5 Durvet Recent Development
11.7 First Priority
11.7.1 First Priority Company Details
11.7.2 First Priority Business Overview
11.7.3 First Priority Pet Anthelmintic Drugs Introduction
11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.7.5 First Priority Recent Development
11.8 Jeffers
11.8.1 Jeffers Company Details
11.8.2 Jeffers Business Overview
11.8.3 Jeffers Pet Anthelmintic Drugs Introduction
11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.8.5 Jeffers Recent Development
11.9 Manna Pro Products
11.9.1 Manna Pro Products Company Details
11.9.2 Manna Pro Products Business Overview
11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.9.5 Manna Pro Products Recent Development
11.10 Merck Animal Health
11.10.1 Merck Animal Health Company Details
11.10.2 Merck Animal Health Business Overview
11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.10.5 Merck Animal Health Recent Development
11.11 Ourofino
11.11.1 Ourofino Company Details
11.11.2 Ourofino Business Overview
11.11.3 Ourofino Pet Anthelmintic Drugs Introduction
11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.11.5 Ourofino Recent Development
11.12 TTK Healthcare
11.12.1 TTK Healthcare Company Details
11.12.2 TTK Healthcare Business Overview
11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.12.5 TTK Healthcare Recent Development
11.13 Vetoquinol
11.13.1 Vetoquinol Company Details
11.13.2 Vetoquinol Business Overview
11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.13.5 Vetoquinol Recent Development
11.14 Virbac
11.14.1 Virbac Company Details
11.14.2 Virbac Business Overview
11.14.3 Virbac Pet Anthelmintic Drugs Introduction
11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.14.5 Virbac Recent Development
11.15 Zoetis
11.15.1 Zoetis Company Details
11.15.2 Zoetis Business Overview
11.15.3 Zoetis Pet Anthelmintic Drugs Introduction
11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2020-2025)
11.15.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of External
Table 3. Key Players of Internal
Table 4. Key Players of Composite
Table 5. Key Players of Injection
Table 6. Global Pet Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pet Anthelmintic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pet Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pet Anthelmintic Drugs Market Share by Region (2020-2025)
Table 10. Global Pet Anthelmintic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pet Anthelmintic Drugs Market Share by Region (2026-2031)
Table 12. Pet Anthelmintic Drugs Market Trends
Table 13. Pet Anthelmintic Drugs Market Drivers
Table 14. Pet Anthelmintic Drugs Market Challenges
Table 15. Pet Anthelmintic Drugs Market Restraints
Table 16. Global Pet Anthelmintic Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pet Anthelmintic Drugs Market Share by Players (2020-2025)
Table 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2024)
Table 19. Ranking of Global Top Pet Anthelmintic Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pet Anthelmintic Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pet Anthelmintic Drugs, Headquarters and Area Served
Table 22. Global Key Players of Pet Anthelmintic Drugs, Product and Application
Table 23. Global Key Players of Pet Anthelmintic Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Anthelmintic Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Pet Anthelmintic Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pet Anthelmintic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Elanco Company Details
Table 49. Elanco Business Overview
Table 50. Elanco Pet Anthelmintic Drugs Product
Table 51. Elanco Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 52. Elanco Recent Development
Table 53. Boehringer Ingelheim Company Details
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Pet Anthelmintic Drugs Product
Table 56. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 57. Boehringer Ingelheim Recent Development
Table 58. Ceva Sante Animale Company Details
Table 59. Ceva Sante Animale Business Overview
Table 60. Ceva Sante Animale Pet Anthelmintic Drugs Product
Table 61. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 62. Ceva Sante Animale Recent Development
Table 63. Chanelle Group Company Details
Table 64. Chanelle Group Business Overview
Table 65. Chanelle Group Pet Anthelmintic Drugs Product
Table 66. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 67. Chanelle Group Recent Development
Table 68. Dechra Company Details
Table 69. Dechra Business Overview
Table 70. Dechra Pet Anthelmintic Drugs Product
Table 71. Dechra Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 72. Dechra Recent Development
Table 73. Durvet Company Details
Table 74. Durvet Business Overview
Table 75. Durvet Pet Anthelmintic Drugs Product
Table 76. Durvet Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 77. Durvet Recent Development
Table 78. First Priority Company Details
Table 79. First Priority Business Overview
Table 80. First Priority Pet Anthelmintic Drugs Product
Table 81. First Priority Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 82. First Priority Recent Development
Table 83. Jeffers Company Details
Table 84. Jeffers Business Overview
Table 85. Jeffers Pet Anthelmintic Drugs Product
Table 86. Jeffers Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 87. Jeffers Recent Development
Table 88. Manna Pro Products Company Details
Table 89. Manna Pro Products Business Overview
Table 90. Manna Pro Products Pet Anthelmintic Drugs Product
Table 91. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 92. Manna Pro Products Recent Development
Table 93. Merck Animal Health Company Details
Table 94. Merck Animal Health Business Overview
Table 95. Merck Animal Health Pet Anthelmintic Drugs Product
Table 96. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 97. Merck Animal Health Recent Development
Table 98. Ourofino Company Details
Table 99. Ourofino Business Overview
Table 100. Ourofino Pet Anthelmintic Drugs Product
Table 101. Ourofino Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 102. Ourofino Recent Development
Table 103. TTK Healthcare Company Details
Table 104. TTK Healthcare Business Overview
Table 105. TTK Healthcare Pet Anthelmintic Drugs Product
Table 106. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 107. TTK Healthcare Recent Development
Table 108. Vetoquinol Company Details
Table 109. Vetoquinol Business Overview
Table 110. Vetoquinol Pet Anthelmintic Drugs Product
Table 111. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 112. Vetoquinol Recent Development
Table 113. Virbac Company Details
Table 114. Virbac Business Overview
Table 115. Virbac Pet Anthelmintic Drugs Product
Table 116. Virbac Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 117. Virbac Recent Development
Table 118. Zoetis Company Details
Table 119. Zoetis Business Overview
Table 120. Zoetis Pet Anthelmintic Drugs Product
Table 121. Zoetis Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 122. Zoetis Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Pet Anthelmintic Drugs Picture
Figure 2. Global Pet Anthelmintic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pet Anthelmintic Drugs Market Share by Type: 2024 VS 2031
Figure 4. External Features
Figure 5. Internal Features
Figure 6. Composite Features
Figure 7. Injection Features
Figure 8. Global Pet Anthelmintic Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pet Anthelmintic Drugs Market Share by Application: 2024 VS 2031
Figure 10. Dog Case Studies
Figure 11. Cat Case Studies
Figure 12. Others Case Studies
Figure 13. Pet Anthelmintic Drugs Report Years Considered
Figure 14. Global Pet Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Pet Anthelmintic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Pet Anthelmintic Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Pet Anthelmintic Drugs Market Share by Players in 2024
Figure 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2024
Figure 20. North America Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 22. United States Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 26. Germany Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pet Anthelmintic Drugs Market Share by Region (2020-2031)
Figure 34. China Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Elanco Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 51. Ceva Sante Animale Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 52. Chanelle Group Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 53. Dechra Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 54. Durvet Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 55. First Priority Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 56. Jeffers Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 57. Manna Pro Products Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 58. Merck Animal Health Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 59. Ourofino Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 60. TTK Healthcare Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 61. Vetoquinol Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 62. Virbac Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 63. Zoetis Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of External
Table 3. Key Players of Internal
Table 4. Key Players of Composite
Table 5. Key Players of Injection
Table 6. Global Pet Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pet Anthelmintic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pet Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pet Anthelmintic Drugs Market Share by Region (2020-2025)
Table 10. Global Pet Anthelmintic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pet Anthelmintic Drugs Market Share by Region (2026-2031)
Table 12. Pet Anthelmintic Drugs Market Trends
Table 13. Pet Anthelmintic Drugs Market Drivers
Table 14. Pet Anthelmintic Drugs Market Challenges
Table 15. Pet Anthelmintic Drugs Market Restraints
Table 16. Global Pet Anthelmintic Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pet Anthelmintic Drugs Market Share by Players (2020-2025)
Table 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2024)
Table 19. Ranking of Global Top Pet Anthelmintic Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pet Anthelmintic Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pet Anthelmintic Drugs, Headquarters and Area Served
Table 22. Global Key Players of Pet Anthelmintic Drugs, Product and Application
Table 23. Global Key Players of Pet Anthelmintic Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Anthelmintic Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Pet Anthelmintic Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pet Anthelmintic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Elanco Company Details
Table 49. Elanco Business Overview
Table 50. Elanco Pet Anthelmintic Drugs Product
Table 51. Elanco Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 52. Elanco Recent Development
Table 53. Boehringer Ingelheim Company Details
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Pet Anthelmintic Drugs Product
Table 56. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 57. Boehringer Ingelheim Recent Development
Table 58. Ceva Sante Animale Company Details
Table 59. Ceva Sante Animale Business Overview
Table 60. Ceva Sante Animale Pet Anthelmintic Drugs Product
Table 61. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 62. Ceva Sante Animale Recent Development
Table 63. Chanelle Group Company Details
Table 64. Chanelle Group Business Overview
Table 65. Chanelle Group Pet Anthelmintic Drugs Product
Table 66. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 67. Chanelle Group Recent Development
Table 68. Dechra Company Details
Table 69. Dechra Business Overview
Table 70. Dechra Pet Anthelmintic Drugs Product
Table 71. Dechra Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 72. Dechra Recent Development
Table 73. Durvet Company Details
Table 74. Durvet Business Overview
Table 75. Durvet Pet Anthelmintic Drugs Product
Table 76. Durvet Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 77. Durvet Recent Development
Table 78. First Priority Company Details
Table 79. First Priority Business Overview
Table 80. First Priority Pet Anthelmintic Drugs Product
Table 81. First Priority Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 82. First Priority Recent Development
Table 83. Jeffers Company Details
Table 84. Jeffers Business Overview
Table 85. Jeffers Pet Anthelmintic Drugs Product
Table 86. Jeffers Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 87. Jeffers Recent Development
Table 88. Manna Pro Products Company Details
Table 89. Manna Pro Products Business Overview
Table 90. Manna Pro Products Pet Anthelmintic Drugs Product
Table 91. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 92. Manna Pro Products Recent Development
Table 93. Merck Animal Health Company Details
Table 94. Merck Animal Health Business Overview
Table 95. Merck Animal Health Pet Anthelmintic Drugs Product
Table 96. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 97. Merck Animal Health Recent Development
Table 98. Ourofino Company Details
Table 99. Ourofino Business Overview
Table 100. Ourofino Pet Anthelmintic Drugs Product
Table 101. Ourofino Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 102. Ourofino Recent Development
Table 103. TTK Healthcare Company Details
Table 104. TTK Healthcare Business Overview
Table 105. TTK Healthcare Pet Anthelmintic Drugs Product
Table 106. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 107. TTK Healthcare Recent Development
Table 108. Vetoquinol Company Details
Table 109. Vetoquinol Business Overview
Table 110. Vetoquinol Pet Anthelmintic Drugs Product
Table 111. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 112. Vetoquinol Recent Development
Table 113. Virbac Company Details
Table 114. Virbac Business Overview
Table 115. Virbac Pet Anthelmintic Drugs Product
Table 116. Virbac Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 117. Virbac Recent Development
Table 118. Zoetis Company Details
Table 119. Zoetis Business Overview
Table 120. Zoetis Pet Anthelmintic Drugs Product
Table 121. Zoetis Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)
Table 122. Zoetis Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Pet Anthelmintic Drugs Picture
Figure 2. Global Pet Anthelmintic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pet Anthelmintic Drugs Market Share by Type: 2024 VS 2031
Figure 4. External Features
Figure 5. Internal Features
Figure 6. Composite Features
Figure 7. Injection Features
Figure 8. Global Pet Anthelmintic Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pet Anthelmintic Drugs Market Share by Application: 2024 VS 2031
Figure 10. Dog Case Studies
Figure 11. Cat Case Studies
Figure 12. Others Case Studies
Figure 13. Pet Anthelmintic Drugs Report Years Considered
Figure 14. Global Pet Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Pet Anthelmintic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Pet Anthelmintic Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Pet Anthelmintic Drugs Market Share by Players in 2024
Figure 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2024
Figure 20. North America Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 22. United States Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 26. Germany Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pet Anthelmintic Drugs Market Share by Region (2020-2031)
Figure 34. China Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pet Anthelmintic Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Elanco Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 51. Ceva Sante Animale Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 52. Chanelle Group Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 53. Dechra Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 54. Durvet Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 55. First Priority Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 56. Jeffers Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 57. Manna Pro Products Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 58. Merck Animal Health Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 59. Ourofino Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 60. TTK Healthcare Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 61. Vetoquinol Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 62. Virbac Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 63. Zoetis Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232